Not Signed In - Researchers Seek Alternative For Leukemia Patients Resistant To Standard Therapies
Mon, 03 Apr 2006 11:00 PM EST
... A study led by researchers from the Howard Hughes Medical Institute has found that dasatinib provides significant benefit in chronic myeloid leukemia (CML) patients resistant to Gleevec® (imatinib), according to a study presented today during the 97th Annual Meeting of the American Association for Cancer Research... click link for more info. ...
Related Topics
- Alternative Medicine
- Leukemia
- Alternative Therapies
- Alternative Therapies Home
- Miscellaneous Alternative Therapies
- Childhood Leukemia
- Leukemia, Childhood
- Chronic Lymphocytic Leukemia
- Leukemia, Chronic Lymphocytic
- Cancer Alternative Therapy
- Drug Resistant Infections
- Complementary medicine
- Vaccinations For HIV/AIDs Patients
- What Your Female Patients Want to Know About Bladder Control
- Smoking Cessation and Continued Risk in Cancer Patients
- Vancomycin-Resistant Enterococci
- Leukemia, Adult Acute
- Chronic Myelogenous Leukemia
- Leukemia, Chronic Myelogenous
- Myelogenous Leukemia, Chronic
email this page
print this page
bookmark this page
feedback on this page
